Literature DB >> 31270148

Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions.

Yaling Dou1,2, Junji Xing1,2, Gangcheng Kong1,2, Guangchuan Wang1,2, Xiaohua Lou1,2, Xiang Xiao1,2, Eric Vivier3, Xian C Li4,2,5, Zhiqiang Zhang4,2.   

Abstract

NK cells play an important role in immune surveillance and protective immunity, mainly through rapid cytokine release and cytolytic activities. But how such responses are negatively regulated remains poorly defined. In this study, we demonstrated that the E3 ubiquitin ligase TRIM29 is a crucial regulator of NK cell functions. We found that TRIM29 was not expressed in resting NK cells, but was readily upregulated following activation, especially after IL-12 plus IL-18 stimulation. The levels of TRIM29 expression were inversely correlated with IFN-γ production by NK cells, suggesting that TRIM29 inhibits NK cell functions. Indeed, deficiency of TRIM29, specifically in NK cells, resulted in an enhanced IFN-γ production and consequently protected mice from murine CMV infection. Mechanistically, we showed that once induced in NK cells, TRIM29 ubiquitinates and degrades the TGF-β-activated kinase 1 binding protein 2 (TAB2), a key adaptor protein in IFN-γ production by NK cells. These results identify TRIM29 as a negative regulator of NK cell functions and may have important clinical implications.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Year:  2019        PMID: 31270148      PMCID: PMC6684831          DOI: 10.4049/jimmunol.1900171

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  The role of IL-18 in innate immunity.

Authors:  S Akira
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

Review 2.  Delivering the kiss of death.

Authors:  Christina M Trambas; Gillian M Griffiths
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

Review 3.  NK cell recognition.

Authors:  Lewis L Lanier
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 4.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

Review 5.  Gamma interferon: a central mediator in atherosclerosis.

Authors:  M L Alfaro Leon; S H Zuckerman
Journal:  Inflamm Res       Date:  2005-10       Impact factor: 4.575

6.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

7.  Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.

Authors:  Khuong B Nguyen; Thais P Salazar-Mather; Marc Y Dalod; Jeffrey B Van Deusen; Xiao-qing Wei; Foo Y Liew; Michael A Caligiuri; Joan E Durbin; Christine A Biron
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

8.  Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells.

Authors:  Athanasios Mavropoulos; Gareth Sully; Andrew P Cope; Andrew R Clark
Journal:  Blood       Date:  2004-09-02       Impact factor: 22.113

Review 9.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

10.  ATF3 regulates MCMV infection in mice by modulating IFN-gamma expression in natural killer cells.

Authors:  Carrie M Rosenberger; April E Clark; Piper M Treuting; Carrie D Johnson; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

View more
  14 in total

1.  TRIM29 is differentially expressed in colorectal cancers of different primary locations and affects survival by regulating tumor immunity based on retrospective study and bioinformatics analysis.

Authors:  Jing Han; Jing Zuo; Xue Zhang; Long Wang; Dan Li; Yudong Wang; Jiayin Liu; Li Feng
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 2.  Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review).

Authors:  Xiuzhen Zhang; Tong Meng; Shuaishuai Cui; Dongwu Liu; Qiuxiang Pang; Ping Wang
Journal:  Int J Oncol       Date:  2022-05-26       Impact factor: 5.884

Review 3.  The MID1 gene product in physiology and disease.

Authors:  Rossella Baldini; Martina Mascaro; Germana Meroni
Journal:  Gene       Date:  2020-04-10       Impact factor: 3.688

4.  TRIM26 positively regulates the inflammatory immune response through K11-linked ubiquitination of TAB1.

Authors:  Jian Zhao; Baoshan Cai; Zhugui Shao; Lei Zhang; Yi Zheng; Chunhong Ma; Fan Yi; Bingyu Liu; Chengjiang Gao
Journal:  Cell Death Differ       Date:  2021-05-20       Impact factor: 15.828

Review 5.  The Unique Microbiome and Innate Immunity During Pregnancy.

Authors:  Chunlei Mei; Weina Yang; Xin Wei; Kejia Wu; Donghui Huang
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

Review 6.  Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy.

Authors:  Cai Zhang; Yuxia Liu
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

Review 7.  TAK1-TABs Complex: A Central Signalosome in Inflammatory Responses.

Authors:  Yan-Ran Xu; Cao-Qi Lei
Journal:  Front Immunol       Date:  2021-01-05       Impact factor: 7.561

Review 8.  Targeting ubiquitin signaling for cancer immunotherapy.

Authors:  Xiaofei Zhou; Shao-Cong Sun
Journal:  Signal Transduct Target Ther       Date:  2021-01-13

9.  Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism.

Authors:  Jing Han; Zitong Zhao; Nan Zhang; Yang Yang; Liying Ma; Li Feng; Xue Zhang; Jing Zuo; Zhisong Fan; Yudong Wang; Yongmei Song; Guiying Wang
Journal:  Aging (Albany NY)       Date:  2021-01-20       Impact factor: 5.682

Review 10.  TRIM29 in Cutaneous Squamous Cell Carcinoma.

Authors:  Che-Yuan Hsu; Teruki Yanagi; Hideyuki Ujiie
Journal:  Front Med (Lausanne)       Date:  2021-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.